Tang Capital Management LLC Avrobio, Inc. Transaction History

Tang Capital Management LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$1.15 - $1.48 $980,722 - $1.26 Million	852,802 New	852,802 $1.09 Million
Q2 2023 Aug 14, 2023	BUY	$0.58 - $1.31 $1.55 Million - $3.49 Million	2,667,387 Added 7091.66%	2,705,000 $2.57 Million
Q1 2023 May 15, 2023	BUY	$0.76 - $1.82 $28,585 - $68,455	37,613 New	37,613 $37,000
Q4 2020 Feb 16, 2021	SELL	$12.79 - $17.1 $8.95 Million - $12 Million	-700,000 Closed	0 $0
Q3 2020 Nov 16, 2020	SELL	$12.99 - $19.41 $1.3 Million - $1.94 Million	-100,000 Reduced 12.5%	700,000 $9.11 Million
Q2 2020 Aug 14, 2020	SELL	$12.19 - $22.96 $2.44 Million - $4.59 Million	-200,000 Reduced 20.0%	800,000 $14 Million
Q4 2019 Feb 14, 2020	BUY	$13.05 - $21.88 $2.23 Million - $3.74 Million	170,879 Added 20.61%	1,000,000 $20.1 Million
Q3 2019 Nov 14, 2019	BUY	$14.12 - $23.44 $11.7 Million - $19.4 Million	829,121 New	829,121 $11.7 Million

559K

Ticker AVRO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,773,900
Description
AVROBIO, Inc., a clinical-stage gene therapy company, develops ex vivo lentiviral-based gene therapies to treat rare diseases following a single dose worldwide. Its gene therapies employ hematopoietic stem cells that are collected from patients and modified with a lentiviral vector to insert functional copies of the gene that is defective in the...

Get notified when there are updates to the investment portfolio of Tang Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Tang Capital Management LLC with notifications on news.